Amarin Corp. Plc (AMRN)
12.35
-0.37
(-2.91%)
USD |
NASDAQ |
Oct 02, 16:00
12.38
+0.02
(+0.20%)
After-Hours: 20:00
Amarin Enterprise Value : -50.22M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | -50.22M |
| October 01, 2026 | -42.45M |
| September 30, 2026 | -36.57M |
| September 29, 2026 | -33.63M |
| September 28, 2026 | -31.32M |
| September 25, 2026 | -32.37M |
| September 24, 2026 | -27.54M |
| September 23, 2026 | -21.44M |
| September 22, 2026 | -20.81M |
| September 21, 2026 | -26.49M |
| September 18, 2026 | -23.34M |
| September 17, 2026 | -18.29M |
| September 16, 2026 | -18.92M |
| September 15, 2026 | -17.03M |
| September 14, 2026 | -15.56M |
| September 11, 2026 | -19.76M |
| September 10, 2026 | -14.72M |
| September 09, 2026 | -7.373M |
| September 08, 2026 | -10.31M |
| September 04, 2026 | -23.34M |
| September 03, 2026 | -21.65M |
| September 02, 2026 | -21.86M |
| September 01, 2026 | -18.82M |
| August 31, 2026 | -18.08M |
| August 28, 2026 | -16.19M |
| Date | Value |
|---|---|
| August 27, 2026 | -14.09M |
| August 26, 2026 | -7.688M |
| August 25, 2026 | -12.41M |
| August 24, 2026 | -18.92M |
| August 21, 2026 | -13.67M |
| August 20, 2026 | -14.30M |
| August 19, 2026 | -7.583M |
| August 18, 2026 | -12.83M |
| August 17, 2026 | -15.35M |
| August 14, 2026 | -14.09M |
| August 13, 2026 | -12.41M |
| August 12, 2026 | -14.30M |
| August 11, 2026 | -15.35M |
| August 10, 2026 | -13.25M |
| August 07, 2026 | -8.003M |
| August 06, 2026 | -10.10M |
| August 05, 2026 | -6.953M |
| August 04, 2026 | -7.163M |
| August 03, 2026 | -12.62M |
| July 31, 2026 | -10.10M |
| July 30, 2026 | -10.73M |
| July 29, 2026 | -12.20M |
| July 28, 2026 | -16.61M |
| July 27, 2026 | -19.55M |
| July 24, 2026 | -25.02M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Neurocrine Biosciences, Inc. | 14.56B |
| Alkermes Plc | 7.911B |
| Liquidia Corp. | 2.451B |
| Akari Therapeutics Plc | 8.202M |
| DBV Technologies SA | 411.48M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.664M |
| Revenue (Quarterly) | 42.29M |
| Total Expenses (Quarterly) | 49.95M |
| EPS Diluted (Quarterly) | -0.3681 |
| Gross Profit Margin (Quarterly) | 34.00% |
| Profit Margin (Quarterly) | -18.12% |
| Earnings Yield | -10.51% |
| Normalized Earnings Yield | -5.944 |